Snowball logo
logo
6887

SUNSHINE LAKE PHARMA CO LTD

6887 • HK
HK$40.38-HK$0.82  (1.99%)
Estimate
Beta
-0.191
About the company
Ticker
6887
ISIN
Country
China
Sector (GICS)
Other
Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology. It offers Kewei for the treatment of influenza; Dongweien and Dongyinghe for the treatment of hepatitis C. The company also engages in the import, export, wholesale, retail, and distribution of pharmaceutical products, intermediates, and active pharmaceutical ingredients; product quality inspection; research and development of biosimilar drugs and new biologic; research and production of generic drug; pharmaceutical information consultation, analysis and investigation and pharmaceutical market promotion; and research, development production, and sales of chemical raw material drugs and chemical preparations. The company was formerly known as Sunshine Lake Pharma Ltd. The company was established in 2001 and is based in Dongguan, China.

Frequently asked questions

What sector does SUNSHINE LAKE PHARMA CO LTD (6887) operate in?

SUNSHINE LAKE PHARMA CO LTD belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is SUNSHINE LAKE PHARMA CO LTD (6887) current stock price?

As of the latest data, SUNSHINE LAKE PHARMA CO LTD stock price is HK$40.38, with a previous close of HK$41.20. SUNSHINE LAKE PHARMA CO LTD lost -HK$0.82 in the last trading session, representing a -1.99% loss.

What is SUNSHINE LAKE PHARMA CO LTD (6887) current market capitalization?

SUNSHINE LAKE PHARMA CO LTD market cap is approximately 12.87 billion.

Does SUNSHINE LAKE PHARMA CO LTD (6887) pay dividends?

No. SUNSHINE LAKE PHARMA CO LTD does not pay a dividend.

What is SUNSHINE LAKE PHARMA CO LTD (6887) beta (volatility) score?

SUNSHINE LAKE PHARMA CO LTD has a beta of -0.191, indicating lower volatility than the overall market.